On 2026/4/20, Shenzhen Jianlitong Intelligent Robotics Co., Ltd. (hereinafter "Jianlitong") officially moved to Building D2, Phase 2, Nanshan Zhiyuan, Liuxian Avenue, Nanshan District, Shenzhen. This relocation marks not only a comprehensive upgrade of our office environment but also a strategic milestone for deepening our product portfolio, accelerating talent acquisition, and launching a new phase of high-quality development.

On the same day, Mr. Chen Hongchao, Chairman of Jingrui Medical Group, and his team visited the new office for inspection and guidance. Mr. Hu Feng, General Manager of Jianlitong, led staff from all departments to warmly welcome them and accompanied them throughout the tour and discussions.

New Location, New Look: Building a Higher Ground for Development

Jianli Tong's new office is located at Nanshan Zhiyuan Phase II, a key life science and technology industrial park in Shenzhen and home to the National High-Performance Medical Device Innovation Center. The park hosts numerous top-tier medical device R&D institutions and innovative companies, offering a superior industrial ecosystem. The new facility integrates a product exhibition hall, R&D department, and marketing department. With clear functional zoning and a modern layout, it provides an ideal physical environment and industrial atmosphere for efficient team collaboration.

This relocation marks a strategic milestone: First, it accelerates the development of new products and expands our product portfolio across the full spectrum from professional medical solutions to consumer goods. Second, it enables us to scale our team, strengthen our R&D, marketing, and sales capabilities, and continuously attract top talent to build an efficient, high-performing elite team. Third, it serves as the foundation for establishing a nationwide sales network covering major cities, significantly boosting brand awareness and market influence. The launch of our new office space embodies the company's transition from technology accumulation to scalable growth, and from regional深耕 to national expansion.

Experience the new product and feel the technological breakthrough

Accompanied by General Manager Hu Feng, Chairman Chen Hongchao and his team first toured the company's product showroom and personally tested the newly developed exoskeleton walking robot.

During the demonstration, Chairman Chen Hongchao gave high praise to both products. He highlighted their impressive technical breakthrough in intent recognition accuracy, which successfully translates cutting-edge algorithms into a seamless user experience. Regarding market potential, he noted that these home-use devices effectively address daily pain points such as mobility assistance for seniors and knee protection, indicating significant growth opportunities. This aligns with the Group's long-term strategy in the rehabilitation sector and its vision of "helping patients stand up and move out." Furthermore, from a strategic perspective, he directed the team to accelerate the commercialization of frontier technologies like brain-computer interfaces to secure a leading position in future industries.

Discussion and Planning for the Future

Subsequently, Chairman Chen Hongchao listened to a comprehensive report by General Manager Hu Feng on Jianlengtong Company's development plan and engaged in an in-depth discussion with the management team, providing guidance on the company's future strategic direction.

Chairman Chen Hongchao noted that the infusion of fresh talent has brought new energy to the team, representing the company's most valuable asset as it embarks on a new chapter. Standing at the strategic level of the entire group, he highlighted that Jingrui Medical has deepened its expertise in energy-based surgery over the years and achieved breakthroughs in core technologies. The company's current push into rehabilitation medicine is a key move to anchor emerging productive forces and deepen the integration of "AI + Healthcare." He emphasized that the group will continue to increase R&D investment in cutting-edge areas such as brain-computer interfaces and embodied intelligence, driving the commercialization of more original and disruptive technological innovations. Chairman Chen clearly stated that Jianlitong bears the group's critical mission in the rehabilitation robotics sector and expressed his expectation for the team to move forward steadfastly from their new location toward the goal of becoming a world-class, respected innovator in medical technology and intelligent manufacturing.

Capture the moment, grow together.

At the conclusion of the event, all attendees gathered for a group photo in the new office space to commemorate this milestone moment.

At a new starting point, Jianlengtong will firmly align with the group's strategic deployment, advancing steadily toward its vision of becoming the global benchmark in rehabilitation and mobility robots. We are committed to achieving this with heightened team morale, an expanded product portfolio, and a robust technological moat.